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Opioid Exposed Mothers and Infants in 
Delaware: Clinical and Legal Considerations
X Michele K. Savin, MSN, NNP- BC; David A. Paul, MD 
Drug use is on the rise in Delaware, as demonstrated by the continued increase in infants born with neonatal 
abstinence syndrome. Thoughtful, evidence based, and coordinated approaches are necessary to impact this problem. 
There is solid evidence that mothers and infants who remain together have improved outcomes. Professional medical 
and nursing societies are unanimous in support of non-punitive approaches to care. Medical professionals, legislators, 
and society in general would benefi t from ongoing education on the addiction disease process in order to best care for 
the increasing number of mother/baby dyads with neonatal abstinence syndrome. 
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Introduction More persons died from drug overdoses in the United 
States in 2014 than during any previous year on record, with 
approximately one and a half times as many deaths than in motor 
vehicle crashes.1 Drug use in the United States (US), including 
in pregnant women, is rising – 4.4 percent of pregnant women 
use illicit drugs, with a much higher rate in women aged 15 to 
25 years. Approximately 180,000 infants annually are born with 
neonatal abstinence syndrome (NAS)2 which can directly affect 
infant development. Many of these infants require prolonged 
hospitalizations and require multifaceted inter-professional skills 
to guide them and their mothers through the period of withdrawal. 
Although there are no formal statewide data on NAS in Delaware, 
the number of infants with the NAS diagnosis has increased from 
105 in 2010 to 173 in 2014 at Christiana Care Health System with a 
concomitant increase in patient days from 1,445 to 3,102 per year.
The American Congress of Obstetricians and Gynecologists (ACOG) 
states that there are multifactorial reasons for drug use, which 
is a biologic and behavioral problem with genetic components.3 
Substance abuse affects more people who are living in poverty, who 
have experienced abuse or trauma, and who are unemployed, or 
have mental illness. This means that a large percentage of women 
who deliver opiate exposed infants are uninsured or on Medicaid. 
In some population-based studies as many as 70 percent or more 
of infants diagnoses with NAS are on Medicaid.4 By one estimate 
Medicaid will pay one trillion dollars for substance abuse over the 
next 20 years.5 This translates into problems for families, health care 
systems, legal systems, and society.
Caring for patients with NAS requires empathy, knowledge, and 
curiosity. It demands experience and stamina. Due to increased 
numbers of opiate exposed mother-infant dyads, the stress and 
challenge of caring for vulnerable families is only increasing. The 
caregiver, mother, and infant are in a continual feedback loop with 
the actions of each affecting the reactions of the other.6,7 Care of the 
opioid addicted mother is not emphasized in most medical training. 
It is a specialty area of its own. Nonjudgmental communication 
that balances needed supports and limits to the actively addicted 
or recovering is not in most medical professionals’ toolbox.8 
Professionals need to expand knowledge and understanding of the 
addiction process and the evidence based interventions that best 
serve mothers and infants.
BACKGROUND
+LOOGH¿QHVDGGLFWLRQDVDµµFKURQLFUHODSVLQJGLVHDVHWKDWLV
characterized by compulsive drug seeking and use, despite 
harmful consequences.”9 Addiction is a disease of both brain 
and behavior, and science has yet to understand the various 
reasons why people use drugs or how drugs affect the brain 
to compel addiction.9 The national increase in NAS has 
been linked to prescription drug use.4 Recent Delaware data 
shows alarming statistics that the top 1 percent of prescribers 
wrote one in four opioid prescriptions in Delaware. The top 
10 percent of prescribers in Delaware wrote two thirds of all 
opioid prescriptions and wrote for the highest daily dosage 
among all states.1
0HGLFDOSURIHVVLRQDOVPD\EHFRQÀLFWHGE\WKHQHHGWRDGYRFDWH
for these vulnerable, sick infants whose issues stem directly 
from maternal actions. Most nurses and physicians are not 
trained in addiction behaviors and the life experiences of those 
with addiction.10,11 This absence of training may impede the 
relationships, and in turn accentuate negative feelings held by the 
mother. The lack of a trusting relationship can mean a mother is 
four times less likely to receive adequate preventive and ongoing 
health care. This may include how to bond with her infant.9
Caregivers without an understanding of the addiction 
experience may reinforce negative behavior such as non-
visitation on the part of the mother.6,7 Additionally, a paucity 
of maternal education on the topic of infant cues and signs of 
withdrawal exhibited by the infant may perpetuate maternal 
actions that exacerbate infant distress.12
CURRENT TRENDS
There is a growing movement nationally to enact punitive 
approaches to the opioid addicted mother. This may be driven 
not by evidence, but by a perceived need to intervene in the 
abuse cycle. Nurses are increasingly raising their voices against 
the mother, advocating for foster care13RUOHJDOUDPL¿FDWLRQV
for the mother. These ideas seem born of frustration rather 
than evidence. Evidence suggests that mothers and infants 
kept together have improved outcomes.14,15 Indeed, the New 
Expectations program under the Delaware Department of 
Corrections is an example of a novel program working to keep 
mothers and infants together while searching for solutions which 
break the cycle of incarceration. Studies have also pointed out 
that mandatory reporting systems create fear of incarceration, 
fear of removal of the infant from parental care, or require entry 
into the social service system. Additionally, mandatory reporting 
can interfere with patient provider relationships.16 The American 
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Nurses Association (ANA) believes the threat of prosecution 
hinders nurses from providing care to women who seek it.17
LEGAL PERSPECTIVE
Mandatory reporting of opiate exposed infants can be used as a 
proxy for local prevalence of maternal opioid use. It may lead to 
interventions by law enforcement or social services. Legislative 
action toward maternal opiate use is variable between states, and 
is creating disparities in care and intervention.18,19 Some state 
policies regarding testing and reporting of mothers and infants 
with opiate exposure are more punitive, focusing primarily on 
the safety of the child, whereas others are more preventative and 
consider the health and well-being of the pregnant woman and 
her newborn. Testing and reporting policies can vary even within 
states.20 Mandatory reporting, therefore, exposes women and 
infants to very disparate outcomes, depending on where they live, 
and how local and state laws are interpreted and enforced.
A recent report from the Guttmacher Institute gives a national 
perspective of state laws. Eighteen states consider substance use 
in pregnancy to be child abuse and three consider it grounds for 
civil commitment. Eighteen states require health care workers to 
report suspected abuse to the state and four mandate testing of 
pregnant women.18 A myriad of other laws exist in counties and 
PXQLFLSDOLWLHVDQGGH¿QLWLRQVRIVXVSHFWHGVXEVWDQFHDEXVHDV
well as who is mandated to report and when are not consistent 
or clear. The potential negative effects that may occur as a result 
of the legal actions taken against prenatal drug abusers are 
many. These negative effects may include, but are not limited 
to avoidance of prenatal care, constitutional infringements, 
discrimination, poor prison conditions, and ineffectiveness of 
punitive measures.5
The punitive approach is aimed at cost reduction and social well-
being. Nationally costs of all infant drug exposure total between 
$71 million and $113 million per year, but in particular, treatment 
for infant opiate exposure is extremely costly.20 However, legal 
action has many negative unintended consequences. ACOG 
states “deterring women from seeking care is detrimental to 
women and infants; seeking care should not expose a woman 
to civil or criminal proceedings which put her and baby at risk 
of incarceration and separation.”3 ACOG also points out that it 
cannot be assumed that a pregnant woman who does not receive 
treatment does not want it, as availability of targeted substance 
abuse treatment for pregnant women is limited to 19 states, with 
only 12 giving pregnant women priority access to treatment.3,18 
Delaware neither gives pregnant women priority access nor 
protects pregnant women from discrimination in publicly funded 
programs.18
PROFESSIONAL RESPONSE
The National Perinatal Association opposes criminal prosecution 
of women who abuse substances while pregnant, as there is no 
evidence that this helps the mother or infant.21 The American 
Society of Addiction Medicine (ASAM) supports treatment rather 
than criminalization as incarceration may hurt the health of the 
mother and fetus, and may not address efforts toward long-term 
recovery.22 In January of 2015 the Association of Women’s Health, 
Obstetric, and Neonatal Nurses (AWHONN) released a position 
statement, which while endorsing a nurses’ responsibility to 
follow the law, opposes incarceration or punitive legal action 
against women due to substance abuse in pregnancy.23
WORKING TOGETHER
The national extent of maternal opioid abuse and resulting NAS 
is not clear, and it is variable around the country. Programs 
aimed at quantifying NAS as a diagnosis, looking at trends in 
geographic areas, and in differing populations are needed. Young 
et al. concluded we may be missing an opportunity to increase 
the impact of policy on the issue of substance use in pregnancy, 
and that solutions require public and private entities to work 
together to address how we serve families. Additionally, there is 
opportunity for partnerships to identify where differences exist in 
policy goals versus implementation of local laws.19
'HLGHQWL¿HGUHSRUWLQJRILQIDQWVH[SRVHGWRRSLDWHVKDV
the potential to provide data to drive interventions and to 
UHGXFHSK\VLFDOHPRWLRQDODQG¿QDQFLDOFRVWVRIWKH1$6
epidemic to individuals and society. Programs such as this are 
underway in Tennessee and Florida, the results of which are 
pending.24,25,26 Screening and reporting should be viewed as 
part of a larger issue of policy and practice interventions for 
individuals and families. In Tennessee, public health partners 
in both the public and private sector are using reporting results 
to enact local prevention strategies.26 Which mechanism to use 
for screening, where to collect and house the data, and how 
the data are used are all questions that need to be addressed. 
Currently in Delaware screening via urine, meconium, and 
more recently, umbilical cord tissue has been used based on 
hospital system policy. All have potential downsides however 
DQGFRVWVHQVLWLYLW\DQGVSHFL¿FLW\YDU\7KHLVVXHRI1$6
UHTXLUHVDFOHDUGH¿QLWLRQRIWHUPVFRQVLVWHQWLPSOHPHQWDWLRQ
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and availability of treatment interventions, all of which are 
challenging. 
FAMILY RESPONSE
Parents of children born with NAS perceived themselves to 
KDYHGLI¿FXOW\EHLQJHPRWLRQDOO\DYDLODEOHDQGUHVSRQVLYH
Additionally, they were often separated from their children by 
incarceration, hospitalization, or drug seeking behaviors. Health 
care professionals must target treatment and support at family 
systems, not just individuals, ensuring continuity of care and 
caregiving for children.27 Interventions will need a systematic 
population health focus. Medicaid will have a role, especially 
given that these infants are at higher risk of re-hospitalization 
than their non-exposed peers.4
HEALTH CARE CHALLENGES
Professionals need up-to-date education regarding substance 
abuse care to decrease challenges and stress. Also needed are 
evidence-based strategies that are shown to aid mother and infant 
through the crucial early withdrawal and bonding moments. 
Mothers may struggle to interpret infant cues and provide 
appropriate care. It is incumbent upon health care professionals 
to asses maternal and infant interactions, improving maternal 
FRQ¿GHQFHLQKHUDELOLW\WRFDUHIRUKHULQIDQW12 thereby creating 
successful mother-infant bonds. 
It is increasingly clear that keeping the opioid exposed mother/
infant dyad together in the same room and breastfeeding 
leads to shorter hospital stays and increased bonding.14,15 Non-
pharmacologic intervention and complementary therapies are 
used in neonates, but they have not been widely studied and use 
is inconsistent. While things like decreased stimulation and skin 
to skin care have anecdotal success, they do not have proven 
HI¿FDF\14,28 Validating and implementing potential interventions 
may go a long way toward increased understanding on the part 
of health care professionals and increased success of the mother/
infant dyad.
CONCLUSION
The number of substance abusing mothers in Delaware is 
increasing. While current national trends may encourage punitive 
responses to these mothers, ever growing bodies of evidence 
show treatment and support are better options for families. 
Professional organizations are unanimous in calling for non-
SXQLWLYHDSSURDFKHV'HLGHQWL¿HGUHSRUWLQJRILQIDQWVH[SRVHG
to opiates may provide data to drive interventions, having the 
SRWHQWLDOWRUHGXFHSK\VLFDOHPRWLRQDODQG¿QDQFLDOFRVWVRIWKH
NAS epidemic to individuals and society. Screening and reporting 
can be viewed as part of a larger issue of policy and practice 
interventions for individuals, families, and communities. Policy 
solutions may include increasing priority for pregnant women 
in treatment centers, increased funding for research on short 
term and long term outcome of infants with NAS, and assisting 
nursing and state agencies to optimize follow up of infants and 
mothers, to name a few. There is a need to educate health care 
professionals, legislators, and society about the addiction disease 
process. Issues such as reasons that lead to opiate abuse should 
be addressed upstream. Finally, the role of both legislation and 
KHDOWKFDUHSURIHVVLRQDOVLQWKH¿JKWDJDLQVWRSLDWHDEXVHQHHGV
VWUXFWXUHDQGFODULW\$OOFLWL]HQVLQ'HODZDUHZLOOEHQH¿WIURPD
coordinated, thoughtful, evidence based approach to this growing 
epidemic.  
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